retatrutide triple agonist weight loss trial Breaking: New data just released. TRIUMPH-1 study results on the agonist. Eli Lilly's clinical trial on Retatrutide (triple compound). 80 weeks. Phase 3 data. The results: At 12mg Eli Lilly's triple agonist, retatrutide,
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1





















:max_bytes(150000):strip_icc()/GettyImages-2169095535-f8d8276415dd4300a867a1f8b7de098f.jpg)




